---
figid: PMC6721815__cancers-11-01176-g003
figlink: /pmc/articles/PMC6721815/figure/cancers-11-01176-f003/
number: F3
caption: Adaptive response-mediated resistance to BRAF inhibitors in melanoma. (A)
  Negative feedback regulation of activated ERK on EGFR, RAF, and MEK, resulting in
  the downregulation of MAPK signalling.  highlights the relief of these downstream
  kinase-dependent negative feedback loops, following MAPK inhibition. (B) Transcriptionally-mediated
  feedback loops regulating resistance to BRAF inhibitors. These feedback loops result
  in re-activation of the MAPK pathway (DUSP, USP28, FOXD3/ERBB3. TGFB/EGFR), parallel
  activation of PI3K pathway (FOXD3/ERBB3, TGFB/EGFR), increase oxidative phosphorylation
  (PGC1α, lncRNA SAMMSON, MITF), and autophagy related genes mediated by TFEB. RAF,
  RAF proto oncogene; MEK/MAPK, mitogen-activated protein kinase; ERK, extracellular
  signal-related kinase. SHC, SHC adaptor protein 1; GRB2, growth factor receptor
  bound protein 2; SOS, son of sevenless; RAS, RAS proto-oncogene; USP28, Ubiquitin
  specific protease 28; KSR, Kinase Suppressor of RAS; EGFR, epidermal growth factor
  receptor; ERBB3, Erb-B2 receptor tyrosine kinase 3; PI3K, Phosphoinositide 3-kinase;
  AKT, AKT serine/threonine kinase; MITF, melanocyte inducing transcription factor;
  SOX10, SRY-box 10; TGFβ, transforming growth factor β, TFEB, transcription factor
  EB; FOXD3, forkhead box D3; DUSP, dual specificity phosphatase; PGC1α, Peroxisome
  proliferator-activated receptor-gamma coactivator (PGC)-1alpha, TF, transcription
  factors.
pmcid: PMC6721815
papertitle: Adaptive Responses as Mechanisms of Resistance to BRAF Inhibitors in Melanoma.
reftext: Azad Saei, et al. Cancers (Basel). 2019 Aug;11(8):1176.
pmc_ranked_result_index: '153916'
pathway_score: 0.9380214
filename: cancers-11-01176-g003.jpg
figtitle: Adaptive response-mediated resistance to BRAF inhibitors in melanoma
year: '2019'
organisms: Homo sapiens
ndex: d5931c5a-df05-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6721815__cancers-11-01176-g003.html
  '@type': Dataset
  description: Adaptive response-mediated resistance to BRAF inhibitors in melanoma.
    (A) Negative feedback regulation of activated ERK on EGFR, RAF, and MEK, resulting
    in the downregulation of MAPK signalling.  highlights the relief of these downstream
    kinase-dependent negative feedback loops, following MAPK inhibition. (B) Transcriptionally-mediated
    feedback loops regulating resistance to BRAF inhibitors. These feedback loops
    result in re-activation of the MAPK pathway (DUSP, USP28, FOXD3/ERBB3. TGFB/EGFR),
    parallel activation of PI3K pathway (FOXD3/ERBB3, TGFB/EGFR), increase oxidative
    phosphorylation (PGC1α, lncRNA SAMMSON, MITF), and autophagy related genes mediated
    by TFEB. RAF, RAF proto oncogene; MEK/MAPK, mitogen-activated protein kinase;
    ERK, extracellular signal-related kinase. SHC, SHC adaptor protein 1; GRB2, growth
    factor receptor bound protein 2; SOS, son of sevenless; RAS, RAS proto-oncogene;
    USP28, Ubiquitin specific protease 28; KSR, Kinase Suppressor of RAS; EGFR, epidermal
    growth factor receptor; ERBB3, Erb-B2 receptor tyrosine kinase 3; PI3K, Phosphoinositide
    3-kinase; AKT, AKT serine/threonine kinase; MITF, melanocyte inducing transcription
    factor; SOX10, SRY-box 10; TGFβ, transforming growth factor β, TFEB, transcription
    factor EB; FOXD3, forkhead box D3; DUSP, dual specificity phosphatase; PGC1α,
    Peroxisome proliferator-activated receptor-gamma coactivator (PGC)-1alpha, TF,
    transcription factors.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3R4
  - PIK3CG
  - PIK3CA
  - PIK3CD
  - PIK3R5
  - PIK3R3
  - PIK3CB
  - TGFB2
  - TGFB3
  - TFEB
  - TGFB1
  - EGFR
  - ERBB3
  - USP28
  - DUSP6
  - PPARGC1A
  - PIK3R6
  - SOX10
  - MAPK11
  - MAPK9
  - MAPK10
  - MAPK14
  - MAPK13
  - MAPK12
  - MAPK1
  - MAP2K2
  - MAP2K1
  - EIF2AK3
  - AKT3
  - AKT1
  - AKT2
  - BRAF
  - DUSP1
  - DUSP2
  - DUSP3
  - DUSP4
  - DUSP5
  - MAPK3
  - ARAF
  - RAF1
  - MITF
  - SHC1
  - GRB2
  - MAPK8
  - SOS1
  - SOS2
  - SHC4
  - SHC3
  - SHC2
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: TFEB)
  symbol: TFEB
  source: hgnc_symbol
  hgnc_symbol: TFEB
  entrez: '7942'
- word: TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: ERBB3
  symbol: ERBB3
  source: hgnc_symbol
  hgnc_symbol: ERBB3
  entrez: '2065'
- word: USP28
  symbol: USP28
  source: hgnc_symbol
  hgnc_symbol: USP28
  entrez: '57646'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP6
  entrez: '1848'
- word: PGC1a↑
  symbol: PGC-1alpha
  source: hgnc_alias_symbol
  hgnc_symbol: PPARGC1A
  entrez: '10891'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: SOX10
  symbol: SOX10
  source: hgnc_symbol
  hgnc_symbol: SOX10
  entrez: '6663'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PERK
  symbol: PERK
  source: hgnc_alias_symbol
  hgnc_symbol: EIF2AK3
  entrez: '9451'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP1
  entrez: '1843'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP2
  entrez: '1844'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP3
  entrez: '1845'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP4
  entrez: '1846'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP5
  entrez: '1847'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MITF
  symbol: MITF
  source: hgnc_symbol
  hgnc_symbol: MITF
  entrez: '4286'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC1
  entrez: '6464'
- word: GRB2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC4
  entrez: '399694'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC3
  entrez: '53358'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC2
  entrez: '25759'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC6721815__F3
redirect_from: /figures/PMC6721815__F3
figtype: Figure
---
